{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:16Z","timestamp":1786119436870,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/coc.0b013e3181b9cedc","type":"journal-article","created":{"date-parts":[[2010,3,27]],"date-time":"2010-03-27T05:24:09Z","timestamp":1269667449000},"page":"489-494","source":"Crossref","is-referenced-by-count":49,"title":["Association Between Polymorphisms of ERCC1 and XPD and Clinical Response to Platinum-Based Chemotherapy in Advanced Non\u2013Small Cell Lung Cancer"],"prefix":"10.1097","volume":"33","author":[{"given":"Fan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","first-page":"230","article-title":"The world health report 2002\u2014reducing risks, promoting healthy life.","volume":"16","author":"Guilbert","year":"2003","journal-title":"Educ Health (Abingdon)"},{"key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.mcp.0000166590.03042.56","article-title":"The treatment of advanced non-small cell lung cancer.","volume":"11","author":"Spiro","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.","volume":"346","author":"Schiller","year":"2002","journal-title":"New Engl J Med"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbrc.2005.03.192","article-title":"The role of p53 in treatment responses of lung cancer.","volume":"331","author":"Viktorsson","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1128\/MCB.24.14.6338-6349.2004","article-title":"Multiple protein-protein interactions by RNA polymerase I-associated factor PAF49 and role of PAF49 in rRNA transcription.","volume":"24","author":"Yamamoto","year":"2004","journal-title":"Mol Cell Biol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","article-title":"Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.","volume":"73","author":"Sancar","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"R8-12-20210128","first-page":"645","article-title":"Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.","volume":"20","author":"Li","year":"2000","journal-title":"Anticancer Res"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1093\/nar\/15.22.9195","article-title":"Genomic characterization of the human DNA excision repair gene ERCC-1.","volume":"15","author":"van Duin","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"R10-12-20210128","first-page":"1123","article-title":"Evidence for order in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues.","volume":"7","author":"Reed","year":"2000","journal-title":"Oncol Rep"},{"key":"R11-12-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0921-8777(00)00051-3","article-title":"DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes.","volume":"461","author":"Vogel","year":"2000","journal-title":"Mutat Res"},{"issue":"suppl 2","key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0169-5002(05)81571-5","article-title":"Applications of genomics in NSCLC.","volume":"50","author":"Rosell","year":"2005","journal-title":"Lung Cancer"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14737159.6.3.319","article-title":"Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.","volume":"6","author":"Bernig","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment.","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"R15-12-20210128","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1002\/elps.200500918","article-title":"An improved gel-based DNA microarray method for detecting single nucleotide mismatch.","volume":"27","author":"Xiao","year":"2006","journal-title":"Electrophoresis"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","article-title":"Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.","volume":"10","author":"Zhou","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(00)00441-X","article-title":"Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.","volume":"60","author":"Ferry","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0215(20000920)89:5<453::AID-IJC9>3.0.CO;2-E","article-title":"ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells.","volume":"89","author":"Britten","year":"2000","journal-title":"Int J Cancer"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.","volume":"19","author":"Shirota","year":"2001","journal-title":"J Clin Oncol"},{"key":"R21-12-20210128","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-04-1387","article-title":"High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.","volume":"11","author":"Joshi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R22-12-20210128","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.","volume":"8","author":"Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0169-5002(03)00151-X","article-title":"Genetic testing for chemotherapy in non-small cell lung cancer.","volume":"41","author":"Rosell","year":"2003","journal-title":"Lung Cancer"},{"key":"R24-12-20210128","first-page":"555","article-title":"Comparison of two human ovarian carcinoma cell lines(A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.","volume":"16","author":"Yu","year":"2000","journal-title":"Int J Oncol"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","article-title":"Single nucleotide polymorphisms and outcome in docetaxel\u2013cisplatin-treated advanced non-small-cell lung cancer.","volume":"15","author":"Isla","year":"2004","journal-title":"Ann Oncol"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"Amultivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer.","volume":"91","author":"Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/1078-0432.1237.11.3","article-title":"Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.","volume":"11","author":"Liu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-04-2216","article-title":"ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin\/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.","volume":"11","author":"Viguier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R30-12-20210128","first-page":"843","article-title":"Association of an ERCC1 polymorphism with adult-onset glioma.","volume":"9","author":"Chen","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s004120050271","article-title":"ASE-1: a novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes.","volume":"106","author":"Whitehead","year":"1997","journal-title":"Chromosoma"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"18173","DOI":"10.1074\/jbc.274.26.18173","article-title":"CAST, a novel CD3e-binding protein transducing activation signal for interleukin-2 production in T cells.","volume":"274","author":"Yamazaki","year":"1999","journal-title":"J Biol Chem"},{"key":"R33-12-20210128","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"R34-12-20210128","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"key":"R35-12-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.critrevonc.2005.01.005","article-title":"Predicting drug response and toxicity based on gene polymorphisms.","volume":"54","author":"Robert","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"R36-12-20210128","first-page":"435","article-title":"Pharmacogenetics in gastrointestinal tumors.","volume":"28","author":"Stohlmacher","year":"2005","journal-title":"Onkologie"},{"key":"R37-12-20210128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2004.12.006","article-title":"Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.","volume":"31","author":"Kweekel","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"R38-12-20210128","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/cncr.23312","article-title":"Multiple gene methylation of non-small cell lung cancers evaluated with 3-dimensional microarray.","volume":"112","author":"Wang","year":"2008","journal-title":"Cancer"},{"key":"R39-12-20210128","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.bios.2006.08.033","article-title":"Bisulfite modification of immobilized DNAs for methylation detection.","volume":"22","author":"Wan","year":"2007","journal-title":"Biosens Bioelectron"},{"key":"R40-12-20210128","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/elps.200600794","article-title":"Gel immobilization of acrylamide-modified single-stranded DNA template for pyrosequencing.","volume":"28","author":"Xiao","year":"2007","journal-title":"Electrophoresis"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-201010000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:24Z","timestamp":1786040124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-201010000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e3181b9cedc","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}